Synthesis and evaluation of a novel samarium-153 bifunctional chelating agent for radioimmunotargeting applications

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 49, Issue 2, 2006, Pages 109-123

  Morandeau, Laurence ^a   Remaud Le Saec, Patricia ^b   Ouadi, Ali ^c   Bultel Rivière, Karine ^b   Mougin Degraef, Marie ^b   De France Robert, Agnès ^b   Faivre Chauvet, Alain ^b   Gestin, Jean François ^b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b INSTITUT DE BIOLOGIE   (France)

^c CENTRE DE CALCUL DE L INSTITUT NATIONAL DE PHYSIQUE NUCLEAIRE ET DE PHYSIQUE DES PARTICULES   (France)

Author keywords

Bifunctional chelating agent; Radioimmunotargeting; Radioimmunotherapy; Samarium 153

Indexed keywords

BODY FLUIDS; SAMARIUM COMPOUNDS;

BIFUNCTIONAL CHELATING AGENT; CONDITION; IN-VIVO; RADIOIMMUNOTARGETING; RADIOIMMUNOTHERAPY; SAMARIUM-153; SYNTHESISED; TRIETHYLENETETRAAMINEHEXAACETIC ACIDS;

CHELATION;

1 (4 ISOTHIOCYANATOBENZYL)TRIETHYLENETETRAAMINEHEXAACETIC ACID; 3 (4 ISOTHIOCYANATOBENZYL)TRIETHYLENETETRAAMINEHEXAACETIC ACID; ACETIC ACID; CHELATING AGENT; SAMARIUM 153; UNCLASSIFIED DRUG;

ARTICLE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ISOTOPE LABELING; RADIOIMMUNOASSAY;

EID: 33644980779     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1031     Document Type: Article

References (18)

1. Goldenberg DM. J Nucl Med 1983; 24: 360-362.
2. Couturier O, Faivre-Chauvet A, Filippovich IV, Thedrez P, Saï-Maurel C, Bardiès M, Mishra AK, Gauvrit M, Blain G, Apostolidis C, Molinet R, Abbé JC. Bataille R, Wijdenes J, Chatal JF, Chérel M. Clin Cancer Res 1999; 5: 3165-3170.
3. Chatal JF, Peltier P, Bardies M, Chetanneau A, Resche I, Mahe M, Charbonnel B. Med Nucl Imag Fonct Metabol 1993; 17: 81-85.
4. Barbet J, Kraeber-Bodere F, Vuillez JP, Gautherot E, Rouvier E, Chatal JF. Cancer Biother Radiopharm 1999; 14(3): 153-166.
5. Rosegrough SF. Q J Nucl Med 1996; 40: 234-251.
6. Bardies M, Chatal JF. Phys Med Biol 1994; 39(6): 961-981.
7. Moi MK, Meares CF. J Am Chem Soc 1998; 110: 6266-6267.
8. Ouadi A, Loussouarn A, Remaud P, Morandeau L, Apostolidis C, Musikas C, Faivre-Chauvet A, Gestin JF. Tetrahedron Lett 2000; 41: 7207-7209.
9. Brechbiel MW, Gansow OA. J Chem Soc Perkin Trans 1992; I: 1173-1178, 2740.
10. Achour B, Costa J, Delgado R, Garrigues E, Geraldea CF, Korber N, Nepveu F. Prata MI. Inorg Chem 1998; 37: 2729-2740.
11. Loussouarn A, Faivre-Chauvet A, Chatal JF, Gestin JF. Mater Sci Forum 1999; 315-317: 262-267.
12. Loussouarn A, Ouadi A, Morandeau L, Remaud P, Giles R, Gestin JF, Webb J. Tetrahedron Lett 2003; 44: 3539-3541.
13. Ouadi A, Loussouarn A, Morandeau L, Remaud P, Faivre-Chauvet A, Webb J, Gestin JF. Europ J Med Chem 2004; 39(5): 467-472.
14. Ouadi A, Bultel K, De France-Robert A, Loussouarn A, Morandeau L, Gestin JF. Tetrahedron Lett 2004; 45(7): 1395-1397.
15. Bhargava KK, Zhang ZY, Palestro CJ, Acharya SA. J Protein Chem 1999; 18(7): 761-770.
16. Corson DT, Meares CF. Bioconjugate Chem 2000; 11: 292-299.
17. Brechbiel MW, Gansow OA. J Chem Soc Perkin Trans 1992; I: 1173-1178.
18. Morandeau L, Benoist E, Loussouarn A, Ouadi A, Lesaeac P, Mougin M, Faivre-Chauvet A, Le Boterff J, Chatal JF, Barbet J, Gestin JF. Bioconjugate Chem 2005; 16: 184-193.